📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-14 19:43
103 analysed today
103
Today
136,623
All-time analysed
40,486
Positive
6,319
Negative
81,881
Neutral
7,869
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
20 announcements match the current filters (relevance ≥ 5).
Q1 FY27 Net Loss at Rs 36.07 Lakhs on Nil Operational Revenue Post-Resolution
Omkar Speciality Chemicals reported zero revenue from operations for the quarter ended June 30, 2026, identical to the nil revenue in the corresponding quarter of the previous year. The company posted a net loss of Rs 36.07 Lakhs for the quarter, marginally narrower than the Rs 40.98 Lakhs loss in Q1 FY26. Total expenses stood at Rs 36.07 Lakhs, consisting mainly of depreciation (Rs 21.73 Lakhs) and other expenses (Rs 13.50 Lakhs). Statutory auditors highlighted the ongoing implementation of the NCLT-approved Resolution Plan dated July 31, 2025, noting that lender dues have been settled as the company prepares to restart commercial operations.
Confidence: HIGH
What changedOmkar Speciality Chemicals submitted its Q1 FY27 financial results reporting continued operational inactivity with a Rs 36.07 Lakhs net loss alongside status notes on its post-NCLT debt settlement.
Why it mattersConfirms that while balance sheet debt settlement under the NCLT resolution plan has been executed, the business has yet to recommence core commercial manufacturing operations.
Revenue from Operations: NilNet Loss (Q1 FY27): Rs 36.07 LakhsDepreciation Expense: Rs 21.73 LakhsPaid-up Equity Capital: Rs 2,057.80 Lakhs
📅 Short termSubdued near-term performance as fixed overheads and depreciation will continue to generate quarterly losses until commercial operations restart.
📈 Long termLong-term viability is entirely contingent on successfully recommissioning manufacturing assets and generating sustained chemical sales post-insolvency.
⚠ Risk flags
- Zero operational revenue generated during the quarter
- Continued quarterly losses eroding net worth
- Operational execution risks in restarting manufacturing facilities post-insolvency
Key Highlights
Revenue from operations was Nil for Q1 FY27, compared to Nil in Q1 FY26 and Rs 0.82 Lakhs in Q4 FY26.
Net loss stood at Rs 36.07 Lakhs versus a net loss of Rs 40.98 Lakhs in the year-ago quarter.
Total expenses of Rs 36.07 Lakhs were dominated by Rs 21.73 Lakhs in depreciation and Rs 13.50 Lakhs in other administrative expenses.
Auditor emphasis of matter noted the implementation of the NCLT Resolution Plan (dated July 31, 2025) and repayment of financial creditors.
👀 What to Watch
Monitor upcoming filings for updates on the actual resumption of commercial manufacturing operations and the revival of operational revenue streams.
Omkar Speciality reports ₹1.58 Cr Net Loss in FY26; ₹23.42 Cr infused via Resolution Plan
Omkar Speciality Chemicals has officially implemented its NCLT-approved resolution plan with Kshitij Polyline Limited as the successful applicant. For FY26, the company reported a net loss of ₹1.58 crore on negligible revenue of ₹0.82 lakhs, as manufacturing operations remain suspended. The resolution applicant has infused ₹23.42 crore into the company as of March 31, 2026, to facilitate revival and debt settlement. Despite negative other equity of ₹1.85 crore, the management is proceeding on a 'going concern' basis following the equity restructuring and fund infusion.
Confidence: HIGH
What changedThe company has emerged from the Corporate Insolvency Resolution Process (CIRP) with a new promoter (Kshitij Polyline) and a restructured balance sheet.
Why it mattersThis represents a total reset for the company; while the debt has been addressed via the resolution plan, the business is currently non-operational and requires a successful restart to generate value.
Net Loss (FY26): ₹158.88 LakhsRevenue (FY26): ₹0.82 LakhsFund Infusion by Applicant: ₹2,342.13 LakhsInfusion vs Market Cap: 334.5%Negative Other Equity: ₹185.33 Lakhs
📅 Short termThe stock may remain volatile as the market digests the formalization of the resolution plan and the current lack of operational revenue.
📈 Long termThe long-term viability depends entirely on the new management's ability to restart the 5 manufacturing units and regain its historical market position in niche specialty chemicals.
⚠ Risk flags
- Suspended manufacturing operations
- Negative equity position
- History of insolvency and payment delays
- Significant reliance on the Resolution Applicant for funding
Key Highlights
Net loss of ₹158.88 Lakhs for FY26, widening from a loss of ₹130.37 Lakhs in the previous year
Total fund infusion of ₹2,342.13 Lakhs by the Resolution Applicant (Kshitij Polyline) as of March 31, 2026
Revenue from operations was nearly non-existent at ₹0.82 Lakhs for the full year due to suspended manufacturing
Paid-up equity share capital restructured to ₹2,057.80 Lakhs following the extinguishment and reissuance of shares
Resolution plan implementation resulted in significant restatement of borrowings, trade payables, and provisions
👀 What to Watch
Investors should closely monitor the timeline for the recommencement of manufacturing operations and the company's ability to scale revenue from the current near-zero base.
OMKARCHEM FY26 Revenue at ₹0.82 Lakh; ₹23.42 Cr Infused via Resolution Plan
Omkar Speciality Chemicals reported near-zero revenue of ₹0.82 Lakh for FY26 as manufacturing operations remain suspended following its insolvency process. The company is currently implementing an NCLT-approved Resolution Plan by Kshitij Polyline Limited, which has infused ₹23.42 Cr as of March 31, 2026. Despite a net loss of ₹1.59 Cr and negative other equity of ₹1.85 Cr, the management has prepared results on a 'going concern' basis, citing expected operational revival. The board has also restructured equity and formed a new Nomination and Remuneration Committee.
Confidence: HIGH
What changedThe company has moved from the Corporate Insolvency Resolution Process (CIRP) to the implementation phase of a resolution plan, involving significant equity restructuring and fresh fund infusion.
Why it mattersThis represents a total reset of the business; the company's survival and future valuation depend entirely on the new management's ability to restart production and utilize the infused capital effectively.
FY26 Revenue: ₹0.82 LakhsFunds Infused by Resolution Applicant: ₹2,342.13 LakhsInfusion vs Market Cap: ~334%FY26 Net Loss: ₹158.88 LakhsNegative Other Equity: ₹185.33 Lakhs
📅 Short termThe stock may remain volatile as the market processes the near-zero revenue and the ongoing operational suspension despite the capital infusion.
📈 Long termThe long-term outlook is entirely dependent on the successful execution of the turnaround plan and the company's ability to regain its historical revenue levels (previously >₹400 Cr).
⚠ Risk flags
- Suspended manufacturing operations
- Negative other equity
- History of insolvency and NCLT proceedings
- Significant management judgment in asset restatement
Key Highlights
Revenue from operations for FY26 was negligible at ₹0.82 Lakh due to suspended production.
Resolution Applicant (Kshitij Polyline) infused ₹2,342.13 Lakhs (₹23.42 Cr) into the company up to March 31, 2026.
Net loss for the financial year ended March 31, 2026, stood at ₹158.88 Lakhs.
Other Equity remains negative at ₹185.33 Lakhs despite the implementation of the resolution plan.
Paid-up Equity Share Capital as of March 31, 2026, is recorded at ₹2,057.80 Lakhs.
👀 What to Watch
Investors should closely monitor the timeline for the recommencement of manufacturing activities and the specific deployment of the ₹3.51 Cr allocated for capex and working capital.
Board Meeting on Aug 7 to Approve Pending Financials for FY23, FY24, and FY25
Omkar Speciality Chemicals has scheduled a board meeting for August 7, 2026, to approve a multi-year backlog of financial results covering FY23, FY24, and FY25. The company was previously under the Corporate Insolvency Resolution Process (CIRP), which caused the suspension of trading and non-submission of results since FY22. This is a critical regulatory step toward potentially resuming trading on the BSE and NSE. Investors should remain cautious as the company's current financial health post-insolvency remains unquantified until these reports are released.
Confidence: HIGH
What changedThe company is initiating the process to regularize its financial reporting after a multi-year hiatus caused by insolvency proceedings.
Why it mattersClearing the reporting backlog is the primary prerequisite for the company to apply for the resumption of trading and provides the first look at the business's viability post-restructuring.
Board Meeting Date: August 07, 2026Financial Years Covered: FY23, FY24, FY25Market Cap: Rs 7 CrPromoter Holding: 95.0%Debt: Rs 3 Cr
📅 Short termThe announcement is a positive procedural step, but since trading is suspended, there will be no immediate market price discovery.
📈 Long termIf the financials reveal a sustainable business model post-CIRP and trading resumes, it could mark a structural turnaround, though the low float remains a liquidity risk.
⚠ Risk flags
- Trading suspension
- Past insolvency (CIRP)
- Multi-year reporting delay
- Extremely low public float (5%)
Key Highlights
Board meeting scheduled for August 7, 2026, to approve results for three consecutive fiscal years (FY23, FY24, FY25).
Backlog includes quarterly results starting from September 2022 through March 2025.
Company was under Corporate Insolvency Resolution Process (CIRP) under the IBC 2016, leading to operational constraints.
Trading in equity shares remains suspended on both BSE and NSE as of the announcement date.
Promoter holding stands at a high 95.0%, indicating very limited public float.
👀 What to Watch
Monitor the outcome of the August 7 board meeting for the actual financial performance and any updates regarding the timeline for revocation of trading suspension.
Omkar Speciality Chemicals Approves Sale of Two Industrial Plots in Badlapur
The Board of Directors of Omkar Speciality Chemicals has approved the sale of two industrial properties in the MIDC Industrial Area, Badlapur. The assets include Plot No. W 83 (880 Sq. Mtrs.) and Plot No. W 93 (720 Sq. Mtrs.). This move appears to be part of an asset monetization or restructuring strategy, as the company's contact details suggest involvement in a Corporate Insolvency Resolution Process (CIRP). Investors should monitor the final sale value and how the proceeds are utilized for debt settlement.
Key Highlights
Approval for sale of Plot No. W 83 measuring 880 Sq. Mtrs. in MIDC Badlapur.
Approval for sale of Plot No. W 93 measuring 720 Sq. Mtrs. in MIDC Badlapur.
The decision was finalized in a Board Meeting held on June 25, 2026.
Company contact information indicates ongoing CIRP (Insolvency) proceedings.
👀 What to Watch
Investors should exercise caution and wait for disclosures regarding the transaction value and the impact on the company's balance sheet. The potential insolvency context makes this a high-risk situation.
Omkar Speciality Chemicals Implements NCLT Resolution Plan; FY26 Results Reported
Omkar Speciality Chemicals Limited has released its financial results for the year ended March 31, 2026, following the implementation of an NCLT-approved Resolution Plan dated July 31, 2025. The auditors have issued an unmodified opinion but included an 'Emphasis of Matter' regarding the company's status as a 'Going Concern' and the significant restatement of assets and liabilities. The company reported a loss for the year, and the resolution process involved the extinguishment and reissuance of equity shares. Additionally, the company has failed to transfer ₹1.21 Lakhs in unclaimed dividends to the IEPF.
Key Highlights
NCLT approved the Resolution Plan on July 31, 2025, resulting in significant restatement of borrowings, trade payables, and equity.
Auditors highlighted a 'Going Concern' uncertainty despite the implementation of the restructuring plan.
The company failed to transfer ₹1.21 Lakhs of unpaid/unclaimed dividends from FY 2014-15 and FY 2015-16 to the Investor Education and Protection Fund (IEPF).
The financial statements for the previous year (FY25) were audited by a different firm, Satya Prakash Natani & Co.
Implementation of the plan included the infusion of funds by the Resolution Applicant and the restatement of certain assets.
👀 What to Watch
Investors should exercise caution as the company remains under a 'Going Concern' emphasis despite the resolution plan. Monitor the company's ability to generate operational cash flows and return to profitability post-restructuring.
Omkar Speciality Appoints Auditor; NCLT Approves Resolution Plan Amid Negative Net Worth
Omkar Speciality Chemicals has appointed M/s. Aabid & Co as Secretarial Auditor for FY 2025-26 following a board meeting on May 27, 2026. The company released delayed limited review reports for the first three quarters of FY 2025-26, noting that a Resolution Plan was approved by the NCLT on July 31, 2025. However, auditors have issued qualified conclusions due to the company's negative net worth and continued losses. Notably, comparative financial figures for FY 2024-25 are unavailable as the company failed to prepare results during its insolvency period.
Key Highlights
NCLT approved a Resolution Plan for the company on July 31, 2025, ending the CIRP phase.
Auditors issued qualified conclusions for Q1, Q2, and Q3 of FY 2025-26 due to negative net worth.
Financial results for the first three quarters of FY 2024-25 were not prepared, leaving no comparative data.
M/s. Aabid & Co, Company Secretaries, appointed as Secretarial Auditor for the financial year 2025-26.
The company continues to report losses, indicating material uncertainty regarding its status as a going concern.
👀 What to Watch
Investors should remain cautious as the company is in a high-risk recovery phase following insolvency. Monitor the successful implementation of the NCLT-approved resolution plan and the stabilization of financial reporting.
Omkar Speciality Chemicals Appoints New Auditors; NCLT Approved Resolution Plan on July 31, 2025
Omkar Speciality Chemicals has appointed M/s. R. R. Tibrewala & Co. as Statutory Auditors following a board meeting on May 27, 2026. The company recently emerged from the Corporate Insolvency Resolution Process (CIRP) with a Resolution Plan approved by the NCLT on July 31, 2025. However, auditors have issued qualified conclusions for the quarters ending June, September, and December 2025 due to negative net worth and continued losses. Additionally, comparative financial data for FY 2024-25 is unavailable as the company failed to prepare results for the first three quarters of that year.
Key Highlights
NCLT approved the company's Resolution Plan on July 31, 2025, ending the CIRP period.
Auditors issued qualified conclusions for three consecutive quarters ending December 31, 2025.
The company reported negative net worth and material uncertainty regarding its ability to continue as a going concern.
Financial results for the first three quarters of FY 2024-25 were not prepared, leaving no comparative data.
M/s. R. R. Tibrewala & Co. was appointed as the new Statutory Auditor to oversee financial reporting.
👀 What to Watch
Investors should exercise extreme caution and wait for the company to demonstrate financial stability and positive cash flow post-resolution. The lack of comparative data and the qualified audit reports indicate significant remaining risks despite the NCLT approval.
Omkar Speciality Chemicals Appoints Dipak Kumar Shaw as CEO; NCLT Resolution Plan Approved
Omkar Speciality Chemicals has appointed Mr. Dipak Kumar Shaw as the new CEO following a board meeting on May 27, 2026. The company recently emerged from the Corporate Insolvency Resolution Process (CIRP) with a resolution plan approved by the NCLT on July 31, 2025. However, the company continues to report losses and maintains a negative net worth, leading to a qualified opinion from auditors for the first three quarters of FY 2025-26. Financial results for the previous year (FY 2024-25) were not prepared, leaving investors without comparative performance data.
Key Highlights
Appointment of Mr. Dipak Kumar Shaw as Chief Executive Officer (CEO) effective May 27, 2026.
Hon’ble NCLT approved the Resolution Plan for the company on July 31, 2025, ending the CIRP period.
Auditors issued a qualified conclusion for Q1, Q2, and Q3 of FY 2025-26 due to negative net worth and material uncertainty.
Comparative quarterly figures for FY 2024-25 are unavailable as results were not prepared during the insolvency process.
Financial results are currently being prepared on a 'going concern' basis following the resolution plan approval.
👀 What to Watch
Investors should exercise extreme caution as the company is in a high-risk recovery phase post-insolvency. Monitor the new CEO's ability to stabilize operations and the company's progress in meeting the terms of the NCLT-approved resolution plan.
Omkar Speciality Appoints Independent Director; NCLT Resolution Plan Approved
Omkar Speciality Chemicals has appointed Mr. Ruhini Kumar Chakraborty as an Independent Director following a board meeting on May 27, 2026. The company is emerging from a Corporate Insolvency Resolution Process (CIRP) with a resolution plan approved by the NCLT on July 31, 2025. However, auditors have issued a qualified conclusion for the 2025 quarterly results, citing negative net worth and persistent losses. Additionally, comparative financial data for FY 2024-25 is unavailable as the company failed to prepare results for the first three quarters of that year.
Key Highlights
Hon'ble NCLT approved the Resolution Plan for the company on July 31, 2025.
Appointment of Mr. Ruhini Kumar Chakraborty (DIN: 08124270) as an Independent Director.
Auditors issued a qualified opinion due to negative net worth and material uncertainty regarding going concern.
Financial results for the first three quarters of FY 2024-25 were not prepared, leaving no comparative data.
The company reported continued losses throughout the quarters ended June, September, and December 2025.
👀 What to Watch
Investors should exercise extreme caution given the negative net worth and qualified audit reports. Monitor the company's ability to implement the NCLT-approved resolution plan and achieve operational stability before considering any position.
Omkar Speciality Chemicals Reports Q3 FY26 Results; NCLT Approves Resolution Plan
Omkar Speciality Chemicals has released its financial results for the quarter ended December 31, 2025, following its emergence from the Corporate Insolvency Resolution Process (CIRP). A Resolution Plan was approved by the Hon’ble NCLT on July 31, 2025, which is now being implemented. However, the company continues to report losses and maintains a negative net worth, leading to a qualified opinion from auditors regarding its status as a going concern. Notably, comparative figures for the previous financial year are unavailable as the company did not prepare results during the CIRP period.
Key Highlights
NCLT approved the Resolution Plan for the company on July 31, 2025.
Auditors issued a qualified conclusion due to negative net worth and material uncertainty regarding going concern.
Comparative quarterly figures for FY 2024-25 are unavailable as results were not prepared during that period.
The company reported continued losses throughout the first three quarters of FY 2025-26.
Financial results were prepared on a going concern basis specifically citing the approved resolution plan.
👀 What to Watch
Investors should remain cautious as the company is in a fragile state post-insolvency with negative net worth. Monitor the successful implementation of the resolution plan and look for operational stability in future filings before making investment decisions.
Omkar Speciality Chemicals Posts Results Post-NCLT Resolution; Auditors Issue Qualified Opinion
Omkar Speciality Chemicals has released financial results for the quarters ending June, September, and December 2025 following the NCLT's approval of its Resolution Plan on July 31, 2025. The auditors have issued a qualified opinion, highlighting that the company has a negative net worth and continues to incur losses, which creates material uncertainty regarding its status as a going concern. Additionally, comparative figures for the previous financial year (2024-25) are unavailable because the company did not prepare results while under the Corporate Insolvency Resolution Process (CIRP). While the approved plan provides a framework for recovery, the current financial position remains highly distressed.
Key Highlights
NCLT approved the company's Resolution Plan on July 31, 2025, ending the CIRP phase.
Auditors issued a qualified conclusion due to negative net worth and persistent losses during the reviewed periods.
Comparative financial data for the first three quarters of FY 2024-25 is missing as results were not prepared.
Financial statements for June, September, and December 2025 were all signed off on May 27, 2026.
Results were prepared on a going concern basis solely due to the subsequent approval of the resolution plan.
👀 What to Watch
Investors should avoid fresh positions until the company demonstrates operational stability and a clear path to positive net worth under the new resolution plan. The lack of comparative data and the qualified audit report make it difficult to assess the true pace of recovery.
Omkar Speciality Chemicals Reports Q1-Q3 FY26 Results; NCLT Approves Resolution Plan
Omkar Speciality Chemicals has released its delayed financial results for the first three quarters of FY 2025-26, revealing continued losses and a negative net worth. The company was under the Corporate Insolvency Resolution Process (CIRP) during the period, with a Resolution Plan finally approved by the NCLT on July 31, 2025. Auditors have issued a qualified opinion due to the lack of comparative figures from the previous year and significant uncertainty regarding the company's ability to continue as a going concern. These results were finalized significantly late, in May 2026, reflecting the administrative challenges during the insolvency process.
Key Highlights
Resolution Plan approved by Hon’ble NCLT on July 31, 2025, providing a potential path for recovery.
Auditors issued a qualified conclusion citing negative net worth and material uncertainty over going concern status.
No comparative quarterly figures available for FY 2024-25 as the company failed to prepare results for those periods.
Company reported persistent losses across the quarters ended June, September, and December 2025.
Financial results for all three quarters were delayed and only signed off by auditors on May 27, 2026.
👀 What to Watch
Investors should remain highly cautious as the company is in a fragile state with negative net worth and is only now emerging from insolvency. Closely monitor the execution of the NCLT-approved resolution plan and wait for stabilized financial reporting before considering any position.
Omkar Speciality Chemicals to Hold Monitoring Committee Meeting on May 27, 2026
Omkar Speciality Chemicals, currently under the Corporate Insolvency Resolution Process (CIRP), has scheduled a Monitoring Committee meeting for May 27, 2026. The committee will review and approve pending financial results for the quarters ended June, September, and December 2025. Key leadership appointments are on the agenda, including a new CEO and an Independent Director, alongside the reconstitution of essential board committees. This meeting marks a critical step in regularizing governance and financial reporting following the company's admission into CIRP in December 2022.
Key Highlights
Approval of unaudited financial statements for three consecutive quarters of 2025 (June, Sept, Dec).
Appointment of Mr. Dipak Kumar Shaw as the Chief Executive Officer (CEO) of the company.
Appointment of Mr. Ruhini Kumar Chakraborty as an Independent Director.
Discussion regarding CIRP costs and the refund of Performance Bank Guarantees (PBG).
Reconstitution of the Audit Committee and Stakeholder’s Relationship Committee.
👀 What to Watch
Investors should closely monitor the upcoming financial disclosures to assess the company's current valuation and operational state. Extreme caution is advised as the company remains under the insolvency resolution framework.
Omkar Speciality Chemicals to Reduce Share Capital to Nil Under Resolution Plan
Omkar Speciality Chemicals has announced a restructuring plan following its NCLT-approved resolution plan dated July 31, 2025. The plan involves reducing the entire existing share capital of the company to zero, effectively wiping out all current equity shareholders. Following this, fresh equity shares will be issued to the Resolution Applicant (RA) at a face value of INR 10, giving them 100% ownership. To meet SEBI's Minimum Public Shareholding requirements, the RA will later conduct an Offer for Sale (OFS) of 5% of the equity.
Key Highlights
Existing share capital to be reduced to NIL as per NCLT order dated July 31, 2025
Resolution Applicant (RA) to be issued fresh equity shares at INR 10 face value
RA will hold 100% of the company's paid-up capital post-allotment
Company to conduct a 5% Offer for Sale (OFS) to achieve Minimum Public Shareholding
The company has been under Corporate Insolvency Resolution Process (CIRP) since December 5, 2022
👀 What to Watch
Current equity shareholders will lose their entire investment as the share capital is being reduced to zero. Investors should exercise extreme caution as existing shares will hold no value under the approved resolution plan.
Omkar Speciality to Cancel All Existing Shares on April 29; Appoints New CFO and CS
Omkar Speciality Chemicals is implementing its NCLT-approved Resolution Plan, which mandates the 100% cancellation of all existing promoter and public equity shares. The record date for this extinguishment is fixed for April 29, 2026, meaning current shareholders will lose their entire investment value. To facilitate the turnaround, the company is issuing 50 lakh new equity shares at ₹10 each to IFFAS Kshitij SPV LLP and raising a loan of up to ₹20 crore. New management, including a CFO and Company Secretary, has been appointed to lead the restructured entity.
Key Highlights
100% of existing promoter and public equity shares to be extinguished on the record date of April 29, 2026
Issuance of 50,00,000 new equity shares at ₹10 each to IFFAS Kshitij SPV LLP for a total of ₹5 crore
Approval to raise up to ₹20 crore via loan from Kshitij Polyline Limited as per the Resolution Plan
Appointment of Mahendra Kumar Jain as Chief Financial Officer and Kuldeep Menaria as Company Secretary
Resolution Plan implementation follows the NCLT Mumbai bench order dated July 31, 2025
👀 What to Watch
Existing shareholders should note that their equity holdings will be cancelled with zero value on April 29, 2026. Investors are advised to avoid the stock as the current equity is being completely wiped out under the IBC process.
Omkar Speciality Chemicals to Cancel Entire Share Capital; Record Date April 29, 2026
Omkar Speciality Chemicals has announced April 29, 2026, as the record date for the total extinguishment and cancellation of its existing paid-up share capital. This action is being taken pursuant to a Resolution Plan approved by the NCLT Mumbai bench on July 31, 2025, under the Insolvency and Bankruptcy Code. The cancellation applies to all equity shares of INR 10 each held by both the Promoters and the Public Shareholders. Consequently, existing equity holders will see their investment value reduced to zero as the shares are wiped out.
Key Highlights
Record date for share cancellation fixed as April 29, 2026.
100% of equity shares held by Promoters and Public Shareholders will be extinguished.
The move follows the NCLT order dated July 31, 2025, approving the Resolution Plan.
Company has been under the Corporate Insolvency Resolution Process (CIRP) since December 5, 2022.
👀 What to Watch
Existing shareholders will lose their entire investment as the equity is being cancelled; investors should exit any remaining positions immediately if liquidity permits. The stock will likely be delisted or suspended following the capital extinguishment.
Omkar Speciality to Cancel All Existing Equity Shares; Sets Record Date for April 29, 2026
Omkar Speciality Chemicals is implementing its NCLT-approved resolution plan, which mandates the 100% extinguishment of all existing promoter and public equity shares. The record date for this cancellation is fixed for April 29, 2026, meaning current shareholders will lose their entire holdings with no mentioned compensation. To restart operations under new ownership, the company will issue 50 lakh new shares to IFFAS Kshitij SPV LLP for ₹5 crore. Furthermore, it has approved a ₹20 crore loan from Kshitij Polyline Limited and appointed a new CFO and Company Secretary to lead the restructured entity.
Key Highlights
100% of existing promoter and public equity shares to be cancelled/extinguished on the record date of April 29, 2026.
Issuance of 50,00,000 new equity shares at ₹10 each to IFFAS Kshitij SPV LLP for a total of ₹5 crore.
Approval to raise a loan of up to ₹20 crore from Kshitij Polyline Limited to fund the resolution plan.
Treatment of Earnest Money Deposit as debt/loan forming part of the ₹21.90 crore funding requirement.
Appointment of Mahendra Kumar Jain as CFO and Kuldeep Menaria as Company Secretary and Compliance Officer.
👀 What to Watch
Existing shareholders should be aware that their entire investment will be wiped out as shares are being cancelled per the NCLT order. Avoid any fresh positions as the current equity will cease to exist after the record date.
Omkar Speciality Chemicals Clarifies Record Date to be Fixed in April 15 Monitoring Committee Meet
Omkar Speciality Chemicals, which has been under the Corporate Insolvency Resolution Process (CIRP) since December 2022, has issued a clarification regarding its upcoming Monitoring Committee meeting. The company stated that April 15, 2026, will not be the record date as previously suggested, but rather the date on which the record date will be decided. The finalized record date will comply with regulatory requirements, ensuring a minimum gap of seven working days from the meeting date. This update is part of the ongoing resolution process overseen by the Monitoring Committee.
Key Highlights
Clarified that April 15, 2026, is the meeting date and not the record date for corporate actions.
The revised record date will be determined during the Monitoring Committee meeting on April 15, 2026.
The record date will maintain a mandatory minimum gap of 7 working days from the meeting date.
Company remains under Corporate Insolvency Resolution Process (CIRP) since the December 5, 2022, order.
👀 What to Watch
Investors should monitor the outcome of the April 15 meeting for the finalized record date and details on the resolution plan. Due to the ongoing CIRP, the stock remains high-risk and subject to significant restructuring outcomes.
Omkar Speciality to Cancel All Existing Equity Shares; New ₹5 Cr Private Placement Planned
Omkar Speciality Chemicals is proceeding with its NCLT-approved Resolution Plan, which involves the total extinguishment of all existing promoter and public equity shares. A Monitoring Committee meeting on April 15, 2026, will finalize the record date for this cancellation, effectively wiping out current shareholders. Following the wipe-out, the company will issue 5,000,000 new equity shares at ₹10 each to raise ₹5 crore through a private placement. The company is also restructuring its leadership with the appointment of a new CFO and Company Secretary.
Key Highlights
100% extinguishment of all existing equity shares held by both Promoters and Public shareholders
Record date for share cancellation to be determined at the Monitoring Committee meeting on April 15, 2026
Issuance of 50,00,000 new equity shares at ₹10 each for an aggregate of ₹5,00,00,000
Appointment of Mahendra Kumar Jain as CFO and Kuldeep Menaria as Company Secretary
👀 What to Watch
Existing equity holders will lose their entire investment as shares are being cancelled with zero value under the Resolution Plan. Investors should avoid the stock as current holdings will soon be extinguished.
